Follow us twitter facebook
Edition: Global
Click here to subscribe toour free weekly newsletter click here
Companies & industry

Fareva continues to expand internationally

This is one of the breaking news of this fall. The French group Fareva announced late last week the acquisition, on the other side of the Atlantic, of one of the plants located in Richmond, Virginia, which was owned by the Pfizer Group. A manufacturing and packaging unit, which employs 500 people and who therefore add up to a staff of some 6,000 already working for the group Fareva in 28 factories and ten countries. As a consequence, Fareva’s projected turnover will leap this year to 900 million Euros with an almost even distribution between the pharma and the cosmetic activities who, both alone account for 85% of the Group’s activity. A new acquisition that represents an important milestone for the Group’s international expansion. Bernard Fraisse, the CEO tells us more.

Bernard Fraisse, Fareva

Bernard Fraisse, Fareva

This time it’s a deal! The presence of the group of French origin on the other side of the Atlantic is a reality since several days. An essential step for the firm whose head manager, Bernard Fraisse, had always been clear about, concerning its strategic importance. “We just had to choose the right opportunity to increase our influence on this continent, he explains, in both the pharmaceutical and cosmetic fields. And this production unit has everything it takes to achieve this thanks to its talented teams and its excellent industrial tool.

The Richmond plant will continue to undertake manufacturing and conditioning operations for Pfizer. This take over for Fareva, is part of a true acceleration in the company’s international development which now operates in ten countries “and should, in two years time be setting foot in Asia”, reveals Bernard Fraisse!

The Brazilian project

For now, the other major project is located in Brazil where the company started in July 2010 the construction of a factory whose buildings extend over more than two hectares for the filling and packaging of eaux de toilette and aerosols. An investment divided into three tranches which will amount in the end to 42 million euros and will employ between 700 and 800 people. “The group Avon is an important partner in this operation, emphasises Bernard Fraisse, since we will be able to guarantee him the conditioning of more than 150 million units per year.” To note that the Tubex group is also an important stakeholder with the supply of aerosols and tubes. “Certainly a perfect platform too, explains Fareva’s CEO, to seize future growth opportunities in the make-up sector of this continent.

A 2011 year also marked for the group with several other industrial investments with for example the commissioning of a second site in Turkey (foaming products and creams), not to mention Russia (foaming products and eaux de toilette) and the start of a second conditioning line for aerosols in Wales.

Jean-Yves Bourgeois

© 2011 - Premium Beauty News -
latest news
MakeUp in newYork hosted more than 3800 visitors, with a growth of 12% of international guests.

MakeUp in New York moves to Javits Center to continue growing

The latest edition of MakeUp in NewYork was a huge success, announced the organisers. Held at the Center415 on 5th Avenue, in Manhattan, on September 11&12, 2019, the two-day B2B event dedicated to the makeup and skincare supply chain welcomed more than 3800 visitors, with a growth of 12% of international guests. Brazil, Canada, (...)

read more
job opportunities
Experts’ views
Victoria's Secret or the failure of a conservative positioning?

Laurence Bacilieri
Victoria’s Secret or the failure of a conservative positioning?

When the Victoria’s Secret show was cancelled it didn’t come as a surprise. In May, it was reported by The New York Times that the show would no longer be broadcast on network television. “We must evolve and change to grow. With that in mind, we have decided to re-think the traditional Victoria’s Secret Fashion Show". From 2001 to 2018, (...)

read more


We use cookies to give you a better browsing experience. By continuing your visit to this site, you accept the use of cookies. Read more and set cookies